AB SCIENCE
Patent Owner
Stats
- 19 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Nov 30, 2017 most recent publication
Details
- 19 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 307 Total Citation Count
- Jun 28, 2002 Earliest Filing
- 35 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0340,629 MASITINIB COMBINATION FOR USE IN TREATING BREAST CANCERDec 15, 15Nov 30, 17[A61K, C12Q]
2017/0196,853 USE OF AN INHIBITOR OF KINASE ACTIVITY, PARTICULARLY MASITINIB, FOR TREATMENT OF PROSTATE CANCERJun 02, 14Jul 13, 17[A61K]
2017/0119,760 USE OF MASITINIB FOR THE TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSYOct 28, 16May 04, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8993573 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsNov 26, 13Mar 31, 15[C07D]
8940894 Aminothiazole compounds as kinase inhibitors and methods of using the sameMay 10, 13Jan 27, 15[C07D]
8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsJan 28, 11Sep 16, 14[A61K, A01N, C07D]
8658659 Substituted oxazole derivatives and their use as tyrosine kinase inhibitorsJan 05, 12Feb 25, 14[C07D]
8492545 Aminothiazole compounds as kinase inhibitors and methods of using the sameMar 08, 12Jul 23, 13[A61K, C07D]
8450302 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsJan 28, 11May 28, 13[A61K, A01N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0020,867 USE OF MASITINIB FOR THE TREATMENT OF CROHN'S DISEASEAbandonedJul 21, 16Jan 26, 17[A61K]
2016/0263,110 USE OF MASITINIB FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSISAbandonedNov 04, 14Sep 15, 16[A61K]
2015/0290,235 USE OF SMALL MOLECULE INHIBITORS/ACTIVATORS IN COMBINATION WITH (DEOXY)NUCLEOSIDE OR (DEOXY)NUCLEOTIDE ANALOGS FOR TREATMENT OF CANCER AND HEMATOLOGICAL MALIGNANCIES OR VIRAL INFECTIONSAbandonedNov 08, 13Oct 15, 15[A61K]
2013/0072,474 TREATMENT OF DEMENTIA OF ALZHEIMER'S TYPE WITH MASITINIBAbandonedMar 09, 11Mar 21, 13[A61K]
2012/0309,706 COMBINED TREATMENT OF PANCREATIC CANCER WITH GEMCITABINE AND MASITINIBAbandonedFeb 01, 11Dec 06, 12[A61K, A61P]
2009/0082,360 Use of tyrosine kinase inhibitors for treating CNS disordersAbandonedAug 13, 08Mar 26, 09[A61K, A61P]
2008/0255,141 2-(3-AMINOARYL) AMINO-4-ARYL-THIAZOLES AND THEIR USE AS C-KIT INHIBITORSAbandonedJul 18, 07Oct 16, 08[A61K, C07D]
2008/0242,704 Substituted Oxazole Derivatives and their Use as Tyrosine Kinase InhibitorsAbandonedApr 04, 06Oct 02, 08[A61K, C07D, A61P]
2008/0207,572 Use of Dual C-Kit/Fgfr3 Inhibitors for Treating Multiple MyelomaAbandonedJul 13, 06Aug 28, 08[A61K, A61P]
2008/0146,585 Use Of C-Kit Inhibitors For Treating Inflammatory Muscle Disorders Including Myositis And Muscular DystrophyAbandonedApr 19, 05Jun 19, 08[A61K, A61P]
2008/0039,466 2-(3-Substituted-Aryl) Amino-4-Aryl-Thiazoles As Tyrosine Kinase InhibitorsAbandonedJan 28, 05Feb 14, 08[A61K, C07D, A61P]
2008/0025,916 Tailored Treatment Suitable for Different Forms of MastocytosisAbandonedFeb 27, 04Jan 31, 08[A61K, A61P]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
